Welcome to the University of Toronto Early Stage Technology (UTEST) Program.

Learn More

Latest News

AmacaThera raises $10.3 million to develop post-surgery pain treatment: Globe and Mail

UTEST company, AmacaThera, born from the lab of renowned University of Toronto researcher Molly Shoichet has received $10.3 million from investors to begin human safety trials on an injectable gel that can improve post-surgery pain treatment, the Globe and Mail reports. AmacaThera is built on a gel technology developed by Shoichet, a University Professor in chemical engineering and applied chemistry and biomaterials and biomedical… Read more »

ACTO Acquires CoHealth!

ACTO, the Omnichannel Education and Engagement  platform for life sciences, today announced its acquisition of UTEST company, CoHealth, a mobile application that provides trusted resources for patients and caregivers. The deal is ACTO’s second strategic acquisition since securing $11.5 million this summer, and brings a new division with direct-to-patient education capabilities to ACTO’s SaaS platform. Founded in… Read more »

LegUp Computing Acquired by Microchip!

Microchip Technology Inc. (Nasdaq: MCHP) today announced it acquired UTEST company, LegUp Computing Inc., expanding its Field-Programmable Gate Array (FPGA)-based edge compute solution stack with a high-level synthesis (HLS) tool. Commercialized from University of Toronto research, the LegUp HLS tool will make it easier for a larger community of software engineers to harness the algorithm-accelerating power of… Read more »


UTEST 2017 company, Phenomic AI, which aims to help researchers spot the differences between cells that could be early signs of disease and identify promising drugs, has raised $7.97 million CAD ($6 million USD) in financingThis latest round, which the Phenomic AI classified as seed financing, brings the company’s total raised to date to approximately… Read more »


UTEST 2015 cohort startup, Deep Genomics, has closed a $40 million Series B. This brings the company’s total funding to-date to $61 million. The round was led by Future Ventures and received investments from Amplitude Ventures, Khosla Ventures, Magnetic Ventures, and True Ventures. The financing will be put toward the development of treatments for rare genetic… Read more »

EBT Secures USD$10M Series A

EBT Medical, Inc., a 2018 UTEST company, is developing disruptive neuromodulation therapies for pelvic health disorders, recently secured a USD$10M Series A investment, co-led by two top-tier venture capital firms, SV Health Investors and Genesys Capital. EBT intends to use the funding to further develop its revolutionary noninvasive neuromodulation technology, as well as to pursue… Read more »


UTEST 2018 company, ODAIA an AI-powered software-as-a-service (SaaS) startup has raised $1.6 million in seed funding to help fuel its predictive customer analytics tool. The round as co-led by StandUp Ventures and Panache Ventures, which earlier today announced the final close of its Fund I. ODAIA’s seed round also saw participation from BDC Capital’s Women in Technology… Read more »

AmacaThera raises $3.25M

AmacaThera a UTEST company from 2015, has raised $3.25 million to develop a gel-based drug delivery system that could eliminate the need to give patients powerful painkillers following surgery – a key source of the current opioid crisis. The startup, AmacaThera, is built on a gel technology developed in the U of T lab of Molly Shoichet, Ontario’s… Read more »


UTEST company (cohort 2015), Blue J Legal has raised $9.3 million CAD in a series A round. The round was led by Relay Ventures, with participation from US-based LDV Partners, and returning investors BDC Capital and Mistral Venture Partners. Mistral made an undisclosed investment Blue J Legal in May 2017, though at the time the firm said it… Read more »

Silanna Group acquires Appulse Power!

    Appulse Power Inc., a UTEST company from 2014,  founded by U of T Engineering alumni Ahsan Zaman, Behzad Mahdavikhah, Aleksandar Radić, and Professor Aleksandar Prodić has been acquired by the multinational Silanna Semiconductor for an undisclosed amount. “The success of Appulse is credit to the incredible talent and dedication of my three co-founders,” says Professor Prodić. “This team has brought us… Read more »


Would you like to know more?

Hassan Jaferi
Co-director, UTEST
Kurtis Scissons
Co-director, UTEST

Connect with Us